Recent Updates
Recently added Catalysts
GRDN Positive Sentiment

Guardian Pharmacy Services, Inc. to Report Second Quarter 2026 Financial Results and Host Conference Call

Wednesday, July 15, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Guardian Pharmacy Services, Inc. has announced the release of its second quarter 2026 financial results, which will occur after market close on August 6, 2026. The company will also host a conference call at 4:30 p.m. Eastern Time to discuss these results. Investors can access the call via audio webcast or by phone.
Price reaction · baseline $39.97 (2026-07-15 close) · hit after-hours · clean, no other GRDN news in the window
day 0 close · peak
+1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Guardian Pharmacy Services is set to report financial results, indicating growth.
  • The scheduled conference call shows transparency and engagement with investors.

Full Press Release Details

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that it will release second quarter 2026 financial results after market close on Thursday, August 6, 2026. Management will host a conference call to discuss the results at 4:30 p.m. Eastern Time. Conference Call Details The conference call will be available via audio webcast at https://investors.guardianpharmacy.com and can also be accessed by dialing +1 (833) 461-5787 for participants located in the United

Frequently Asked Questions

When will Guardian Pharmacy report its Q2 2026 results?

Guardian Pharmacy will release its Q2 2026 financial results on August 6, 2026.

What time is the conference call for Q2 2026 results?

The conference call will take place at 4:30 p.m. Eastern Time.

How can I access the conference call?

The conference call can be accessed via audio webcast or by dialing +1 (833) 461-5787.

ShareAdd on Google
Tags: GRDN Viatris Investor Conferences Healthcare Guardian Pharmacy Services financial results conference call Q2 2026
Last updated: Jul 15, 2026

Biotech snapshot

Cash runway
$65M liquidity · $0M/mo burn
Low dilution risk